These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24999320)

  • 1. Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate.
    Maslen H; Faulmüller N; Savulescu J
    Front Syst Neurosci; 2014; 8():107. PubMed ID: 24999320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Human Enhancement: An Overview of the Looming Bioethical and Regulatory Challenges.
    Ricci G
    Front Psychiatry; 2020; 11():53. PubMed ID: 32127792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroethical issues in pharmacological cognitive enhancement.
    Mohamed AD
    Wiley Interdiscip Rev Cogn Sci; 2014 Sep; 5(5):533-549. PubMed ID: 26308743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moral Attitudes Toward Pharmacological Cognitive Enhancement (PCE): Differences and Similarities Among Germans With and Without PCE Experience.
    Pohl S; Boelsen H; Hildt E
    Front Pharmacol; 2018; 9():1451. PubMed ID: 30618746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In search of optimal psychoactivation: stimulants as cognitive performance enhancers.
    Rozenek EB; Górska M; Wilczyńska K; Waszkiewicz N
    Arh Hig Rada Toksikol; 2019 Sep; 70(3):150-159. PubMed ID: 32597132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ethics of elective psychopharmacology.
    Mohamed AD; Sahakian BJ
    Int J Neuropsychopharmacol; 2012 May; 15(4):559-71. PubMed ID: 21396152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.
    Repantis D; Bovy L; Ohla K; Kühn S; Dresler M
    Psychopharmacology (Berl); 2021 Feb; 238(2):441-451. PubMed ID: 33201262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
    Banjo OC; Nadler R; Reiner PB
    PLoS One; 2010 Dec; 5(12):e14322. PubMed ID: 21179461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological Cognitive Enhancement: Current Situation and Perspectives].
    Yamamoto M
    Yakugaku Zasshi; 2022; 142(5):521-526. PubMed ID: 35491158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroscience in the Courtroom: From responsibility to dangerousness, ethical issues raised by the new French law].
    Gkotsi GM; Moulin V; Gasser J
    Encephale; 2015 Oct; 41(5):385-93. PubMed ID: 25439859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distributive justice and cognitive enhancement in lower, normal intelligence.
    Dunlop M; Savulescu J
    Monash Bioeth Rev; 2014; 32(3-4):189-204. PubMed ID: 25743047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implications of methylphenidate use by healthy medical students and doctors in South Africa.
    Beyer C; Staunton C; Moodley K
    BMC Med Ethics; 2014 Mar; 15():20. PubMed ID: 24592964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal electrical stimulation in non-depressed reduces levels of reported negative affects from daily stressors.
    Davis NJ
    Front Hum Neurosci; 2017; 11():63. PubMed ID: 28261075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-pharmacological cognitive enhancement.
    Dresler M; Sandberg A; Ohla K; Bublitz C; Trenado C; Mroczko-Wąsowicz A; Kühn S; Repantis D
    Neuropharmacology; 2013 Jan; 64():529-43. PubMed ID: 22828638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distributive justice, equality and the enhancement of human cognition: A commentary on fairness and 'cognitive doping'.
    Walsh A
    Int J Drug Policy; 2021 Sep; 95():102874. PubMed ID: 32718812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust resilience and substantial interest: a survey of pharmacological cognitive enhancement among university students in the UK and Ireland.
    Singh I; Bard I; Jackson J
    PLoS One; 2014; 9(10):e105969. PubMed ID: 25356917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes toward pharmacological cognitive enhancement-a review.
    Schelle KJ; Faulmüller N; Caviola L; Hewstone M
    Front Syst Neurosci; 2014; 8():53. PubMed ID: 24860438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building Conceptions of Cognitive Enhancement: University Students' Views on the Effects of Pharmacological Cognitive Enhancers.
    London-Nadeau K; Chan P; Wood S
    Subst Use Misuse; 2019; 54(6):908-920. PubMed ID: 30658557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroethical issues in cognitive enhancement: Modafinil as the example of a workplace drug?
    Brühl AB; d'Angelo C; Sahakian BJ
    Brain Neurosci Adv; 2019; 3():2398212818816018. PubMed ID: 32166175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.